madman
Super Moderator
ClinicalTrials.gov
www.clinicaltrials.gov
Study Description
Brief Summary:
This is a prospective, non-blinded study of hypogonadal men with a history of testosterone therapy who became azoospermic or severely oligospermic and wish to avoid symptoms of hypogonadism during their recovery of spermatogenesis in an effort to establish paternity. The study will determine if Natesto can alleviate hypogonadal symptoms while preserving the recovery of spermatogenesis.
Sponsors and Collaborators
University of Florida
Acerus Pharmaceutical
Investigators
Principal Investigator: | Kevin Campbell, MD | University of Florida |